# A Study of ResCure™ to Treat COVID-19 Infection

> **NCT04395716** · PHASE1 · WITHDRAWN · sponsor: **ProgenaBiome**

## Conditions studied

- COVID
- Covid-19
- Corona Virus Infection
- Sars-CoV2
- Coronavirus-19
- SARS Pneumonia
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

## Interventions

- **BIOLOGICAL:** ResCure™

## Key facts

- **NCT ID:** NCT04395716
- **Lead sponsor:** ProgenaBiome
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2021-06
- **Final completion:** 2021-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not ever started
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395716, "A Study of ResCure™ to Treat COVID-19 Infection". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04395716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*